Cancer clinical trials in the region Occitanie
319 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 3
Breast cancer
#NCT06382948
HER2 Negative
HR Positive
Locally Advanced
Metastatic
ESR
1
2
Targeted therapy
Hormone therapy
ESR
Systemic Treatment-Naive
Chemotherapy
IUCT Oncopôle (Toulouse)
MedSIR
Phase 3
Lung cancer
#NCT06881784
#2024-518154-16-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Other KRAS
HRAS
KRAS G12C
KRAS non G12C
KRAS G12D
NRAS
1
2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Hôpital Larrey (Toulouse ), Institut du cancer de Montpellier (Montpellier)
Revolution Medicines, Inc.
Phase 3
Stomach and esophageal cancer
#NCT06901531
#2024-519773-19-00
Stomach
Oesogastric junction
Adenocarcinoma
Locally Advanced
Metastatic
Claudin 18.2
None
Systemic Treatment-Naive
CPS Positive (1 <= X < 5)
CPS Positive (5 <= X < 10)
CPS Positive (X >= 10)
HER2
Immunotherapy
Chemotherapy
Centre Hospitalier de Carcassonne (Carcassonne), Institut du cancer de Montpellier (Montpellier)
Astellas Pharma Développement mondial, Inc.
Phase 3
Colon cancer
Rectal cancer
#NCT06252649
#2022-502352-31-00
Adenocarcinoma
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
Targeted therapy
Targeted therapy
Institut du cancer de Montpellier (Montpellier)
Amgen
Phase 3
Breast cancer
#NCT06790693
#2024-516162-11-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
PIK3CA
None
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre de Cancérologie du Grand Montpellier (Montpellier)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT06790693
#2024-516162-11-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
PIK3CA
1
Hormone therapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
IUCT Oncopôle (Toulouse), Centre de Cancérologie du Grand Montpellier (Montpellier)
Hoffmann-La Roche
Phase 3
Acute leukemia
#NCT06852222
#2024-520154-38-00
Acute myeloid leukemia (AML)
None
Treated / Controled
KMT2A
NPM1
None
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier)
Janssen
Phase 3
Acute leukemia
#NCT04307576
#2022-501050-11-01
Acute lymphoblastic leukemia (ALL)
T-cell (T-ALL)
B-cell (B-ALL)
MYC
None
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Toulouse (Toulouse), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier)
Karolinska University Hospital
Phase 3
Acute leukemia
#NCT05907057
#2022-501709-11
Acute myeloid leukemia (AML)
IDH1/2
None
Systemic Treatment-Naive
Chemotherapy
Centre Hospitalier Universitaire de Toulouse (Toulouse)
Servier
Phase 3
Acute leukemia
#NCT06578247
#2023-507936-20-00
Acute myeloid leukemia (AML)
None
Systemic Treatment-Naive
FLT3-ITD
BCR-ABL
Chemotherapy
IUCT Oncopôle (Toulouse)
Daiichi Sankyo